We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Groundbreaking Procedure Combines New Treatments for Liver Tumors

By HospiMedica International staff writers
Posted on 08 Dec 2025

Removing or destroying liver tumors often requires patients to undergo two separate procedures, exposing them to multiple hospital stays, repeated anesthesia, and longer recovery times. More...

Traditional approaches also rely on less precise techniques when CT imaging is not available in the operating room, limiting accuracy when tumors are hard to reach. Now, a new approach combines robotic liver resection and CT-guided ablation in a single operation to reduce patient burden and improve precision.

This combined procedure was developed and performed at Amsterdam UMC (Amsterdam, Netherlands), where teams integrated robotic surgery with CT-guided interventional oncology workflows inside a hybrid operating room. The method brings together two standard liver tumor treatments—robot-assisted resection and image-guided ablation—within one tightly coordinated surgical session. CT guidance allows real-time visualization of tumor targets during ablation, while robotic instruments support highly controlled liver resection.

During the procedure, surgeons removed tumor tissue robotically and then used CT imaging to guide heat-based ablation of additional lesions, ensuring complete coverage while preserving healthy liver tissue. This dual-modality approach reduces the need for large incisions and avoids staging the treatments separately. Initial use of the technique followed months of preparation, ensuring safe integration of surgical and interventional teams.

A clinical study is now underway at Amsterdam UMC to evaluate safety, feasibility, and early outcomes in 15 patients with liver tumors. The goal is to compare the single-session method with standard, separate procedures to determine its benefits in recovery time, complication rates, and overall effectiveness. Depending on the results, a larger multicenter trial involving additional UMCs is planned.

Performing both treatments at once can significantly reduce strain on patients by avoiding repeat anesthesia and hospital admissions, while advanced ablation technologies can improve precision. The researchers expect this new treatment will become accessible to all patients with liver tumors within three years.

"Until now, these procedures could only be done separately or with less precise techniques through a large incision in the abdomen or traditional laparoscopic surgery without a CT scanner,” said Rutger-Jan Swijnenburg, MD, liver surgeon at Amsterdam UMC and co-developer of the combined procedure. “The patient had to undergo two separate hospital stays and receive anesthesia twice. By performing both procedures within one operation, we minimize the burden on the patient."

Related Links:
Amsterdam UMC


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researcher Penghui Zhao holds up the iNal patch, a wearable medical device that can prevent accidental opioid overdoses. (Photo courtesy of Penghui Zhao)

Smart Patch Could Detect Fentanyl and Deliver Automatic Overdose Aid

Fentanyl overdoses can cause rapid respiratory depression and death, often occurring when no responder is present. Current reversal depends on timely administration of naloxone, which is not always available... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.